JP2023514332A5 - - Google Patents

Info

Publication number
JP2023514332A5
JP2023514332A5 JP2022549495A JP2022549495A JP2023514332A5 JP 2023514332 A5 JP2023514332 A5 JP 2023514332A5 JP 2022549495 A JP2022549495 A JP 2022549495A JP 2022549495 A JP2022549495 A JP 2022549495A JP 2023514332 A5 JP2023514332 A5 JP 2023514332A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
immunogenic composition
gas
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022549495A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023514332A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/018402 external-priority patent/WO2021167996A1/en
Publication of JP2023514332A publication Critical patent/JP2023514332A/ja
Publication of JP2023514332A5 publication Critical patent/JP2023514332A5/ja
Pending legal-status Critical Current

Links

JP2022549495A 2020-02-18 2021-02-17 多糖-タンパク質コンジュゲートを含むa群strep免疫原性組成物 Pending JP2023514332A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202062977886P 2020-02-18 2020-02-18
US62/977,886 2020-02-18
US202063013924P 2020-04-22 2020-04-22
US63/013,924 2020-04-22
US202063090069P 2020-10-09 2020-10-09
US63/090,069 2020-10-09
US202063123293P 2020-12-09 2020-12-09
US63/123,293 2020-12-09
PCT/US2021/018402 WO2021167996A1 (en) 2020-02-18 2021-02-17 Group a strep immunogenic compositions with polysaccharide-protein conjugates

Publications (2)

Publication Number Publication Date
JP2023514332A JP2023514332A (ja) 2023-04-05
JP2023514332A5 true JP2023514332A5 (enExample) 2024-02-27

Family

ID=74860575

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022549495A Pending JP2023514332A (ja) 2020-02-18 2021-02-17 多糖-タンパク質コンジュゲートを含むa群strep免疫原性組成物

Country Status (13)

Country Link
US (1) US20230293658A1 (enExample)
EP (1) EP4106807A1 (enExample)
JP (1) JP2023514332A (enExample)
KR (1) KR20220143107A (enExample)
CN (1) CN115175697A (enExample)
AU (1) AU2021224585A1 (enExample)
BR (1) BR112022016268A2 (enExample)
CA (1) CA3168201A1 (enExample)
IL (1) IL295702A (enExample)
MX (1) MX2022010129A (enExample)
PH (1) PH12022552118A1 (enExample)
TW (1) TW202136285A (enExample)
WO (1) WO2021167996A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230052958A (ko) 2020-08-19 2023-04-20 박사이트, 인코포레이티드 운반-단백질 폴리삭카라이드 접합 방법
EP4294452A4 (en) * 2021-02-17 2025-09-24 Vaxcyte Inc METHODS FOR PURIFYING POLYSACCHARIDES AND CORRESPONDING POLYPEPTIDE CONJUGATES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355255B1 (en) * 1998-12-07 2002-03-12 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
BRPI0821240B8 (pt) * 2007-12-21 2022-10-04 Novartis Ag formas mutantes de estreptolisina o
CN102264444B (zh) 2008-10-27 2015-08-05 诺华股份有限公司 纯化方法
US20140294930A1 (en) 2011-08-04 2014-10-02 The Regents Of The University Of California STREPTOCOCCAL GlcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM
RU2662970C2 (ru) * 2012-09-18 2018-07-31 Новартис Аг Везикулы наружной мембраны
MX2019007910A (es) 2016-12-30 2019-12-05 Sutrovax Inc Conjugados de polipeptido-antigeno con aminoacidos no naturales.

Similar Documents

Publication Publication Date Title
Sharma et al. Recent developments for Pseudomonas vaccines
US20230414740A1 (en) Immunogenic compositions
JP2012504660A5 (enExample)
EP1558280B1 (en) Compositions and methods for treating or preventing pneumococcal infection
CN102366630A (zh) 用于抗医院内感染的免疫的多糖-葡萄球菌表面粘附素载体蛋白缀合物
TW201520336A (zh) 用於癌症標靶治療之含有結合白蛋白的精胺酸去亞胺酶之醫藥組成物
Mansour et al. An improved tobacco mosaic virus (TMV)-conjugated multiantigen subunit vaccine against respiratory tularemia
AU2021223787A1 (en) Propionibacterium acnes prophylactic and therapeutic immune treatment
Khan et al. Immunogenicity and protective efficacy of GroEL (hsp60) of Streptococcus pneumoniae against lethal infection in mice
JP2024506713A5 (enExample)
ES2444693T3 (es) Polipéptido derivado de enterococo y su uso para vacunación
WO2017011338A1 (en) Sortase-mediated coupling of immunogenic polysaccharide-protein conjugates and their use
JP7161729B2 (ja) 多価ワクチン
KR102388325B1 (ko) 저분자화 PRP를 사용한 Hib 컨쥬게이트 백신의 제조방법
Kalland et al. Monoclonal antibodies and superantigens: a novel therapeutic approach
CN113874393A (zh) 对hbv包膜蛋白具有特异性的结合分子
CN105903009A (zh) 一种基于阿拉伯半乳聚糖-聚肌苷酸胞苷酸修饰的结核分枝杆菌亚单位疫苗及其制备方法
JP2010521965A (ja) スタフィロコッカス・エピデルミディス(Staphylococcusepidermidis)に対する防御免疫応答を誘発するポリペプチド
CN112449603A (zh) 链球菌中毒性休克综合征
Holz et al. A Review of Protein-and Peptide-Based Chemical Conjugates: Past, Present, and Future. Pharmaceutics 2023, 15, 600
HK40106055A (en) Immunogenic compositions
CN110898217B (zh) 一种肺炎链球菌疫苗及其制备方法
RU2791256C2 (ru) Иммуногенные композиции
CN108379572A (zh) 一种化脓链球菌HtsA蛋白质疫苗以及制备方法和应用
Byvalov et al. Immunobiological properties of Yersinia pestis antigens